EUVIMEDEUVIMED entdecken
Crossref

Understanding current antenatal Hepatitis C testing and care in maternity services in England

Amoolya Vusirikala, Georgia Threadgold, Rachel Roche, Matthew Hibbert iD, Ruth Simmons, Sharon Webb, Mark Gillyon-Powell, Monica Desai, Sema Mandal

Journal of Perinatal Medicine · 2024

DOI: 10.1515/jpm-2023-0508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Perinatal Medicine, 2024. Verfasst von Amoolya Vusirikala und 8 weiteren Autor:innen. Beteiligte Einrichtung: Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency (UKHSA), London, UK. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Hepatitis C. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Universal opt-out antenatal screening for Hepatitis C virus (HCV) is not currently recommened and it is recommended that maternity services offer risk-based testing. We aimed to investigate antenatal HCV testing and adherence to testing guidance.

Methods

A cross-sectional survey was circulated to maternity service providers between November–December 2020 which included testing policy, training for healthcare staff, and management of women found to be HCV positive. Descriptive data are presented.

Results

A total of 75 questionnaires were returned, representing 48 % of English maternity service providers. 87 % of providers reported offering antenatal HCV risk-based testing. Risk factors used to identify pregnant women for testing varied. Less than 15 % of respondents considered women that were ever homeless or with history of incarceraton or from higher HCV prevalence areas as high risk.

Conclusions

Current antenatal HCV testing practices are inadequate and HCV infection likely goes undiagnosed in pregnancy, especially among vulnerable population groups. In the absence of universal antenatal screening, re-framing antenatal HCV risk-based testing and management as a quality improvement initiative and developing HCV specific pathway guidance for maternity units is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Complications, InfectiousHepatitis CHumansFemalePregnancyCross-Sectional StudiesEnglandPrenatal CareMaternal Health ServicesSurveys and QuestionnairesAdultPrenatal Diagnosis

Stichwörter der Autor:innen

HCV infectionHepatitis CUnited Kingdomantenatal testingpregnancysurvey

Autor:innen und Institutionen

  • Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency (UKHSA), London, UK.
  • NHS England & NHS Improvement, HCV Elimination, London, UK.
  • UKHSA, Infectious Diseases in Pregnancy Screening (IDPS) Programme, London, UK.

ORCID-Profile: Matthew Hibbert

Zitieren

APA

Vusirikala, A., Threadgold, G., Roche, R., Hibbert, M., Simmons, R., Webb, S., Gillyon-Powell, M., Desai, M., & Mandal, S. (2024). Understanding current antenatal Hepatitis C testing and care in maternity services in England. Journal of Perinatal Medicine. https://doi.org/10.1515/jpm-2023-0508

Vancouver

Vusirikala A, Threadgold G, Roche R, Hibbert M, Simmons R, Webb S, et al. Understanding current antenatal Hepatitis C testing and care in maternity services in England. Journal of Perinatal Medicine. 2024. doi:10.1515/jpm-2023-0508

BibTeX
@article{Vusirikala2024,
  author = {Vusirikala, Amoolya and Threadgold, Georgia and Roche, Rachel and Hibbert, Matthew and Simmons, Ruth and Webb, Sharon and Gillyon-Powell, Mark and Desai, Monica and Mandal, Sema},
  title = {Understanding current antenatal Hepatitis C testing and care in maternity services in England},
  journal = {Journal of Perinatal Medicine},
  year = {2024},
  doi = {10.1515/jpm-2023-0508}
}
Kostenlos starten →